(2R,3R,4R,5R)-N-BENZYL-3,4-BIS-(BENZYLOXY)-2-[(BENZYLOXY)-METHYL]-5-PROPYL-PYRROLIDINE-1-CARBOXAMIDE
Compound with spectra: 1 NMR
![(2R,3R,4R,5R)-N-BENZYL-3,4-BIS-(BENZYLOXY)-2-[(BENZYLOXY)-METHYL]-5-PROPYL-PYRROLIDINE-1-CARBOXAMIDE](/api/compound/FOw2uEfABY2.png?ph=true&h=300&w=458 "(2R,3R,4R,5R)-N-BENZYL-3,4-BIS-(BENZYLOXY)-2-[(BENZYLOXY)-METHYL]-5-PROPYL-PYRROLIDINE-1-CARBOXAMIDE")
| SpectraBase Compound ID | FOw2uEfABY2 |
|---|---|
| InChI | InChI=1S/C37H42N2O4/c1-2-15-33-35(42-26-31-20-11-5-12-21-31)36(43-27-32-22-13-6-14-23-32)34(28-41-25-30-18-9-4-10-19-30)39(33)37(40)38-24-29-16-7-3-8-17-29/h3-14,16-23,33-36H,2,15,24-28H2,1H3,(H,38,40)/t33-,34-,35-,36-/m1/s1 |
| InChIKey | SMEVCTFFPBRVQE-MGXDLYCJSA-N |
| Mol Weight | 578.8 g/mol |
| Molecular Formula | C37H42N2O4 |
| Exact Mass | 578.314458 g/mol |
| Enantiomer InChIKey | SMEVCTFFPBRVQE-ZYADHFCISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1R,2R,3R,5S,6R,7AR)-1,2-DIBENZYLOXY-3-(BENZYLOXYMETHYL)-6-HYDROXY-5-METHYLINDOLIZIDINE
(2R,3AR,4R,5R,6R)-4,5-DIBENZYLOXY-6-(BENZYLOXYMETHYL)-2-(2-HYDROXYETHYL)-HEXAHYDROPYRROLO-[1,2-B]-ISOXAZOLE
(1S,5R,6R,7R,8R)-6,7-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-ol
NPFXGQYXZNESPD-VTYCOLDWSA-N
(5S,6R,7R,7AS)-6,7-DIBENZYLOXY-3-OXOTETRAHYDROPYRROLO-[1,2-C]-OXAZOLE-5-CARBONITRILE
(1S,7R,8R,9R,9aS)-7,8,9-tribenzoxyquinolizidin-1-ol
(1R,6S,7S,8R,8aS)-1-hydroxy-6,7,8-tri(benzyloxy)indolizidine
3-ACETAMIDO-1,4-DI-O-ACETYL-2,5,6,7-TETRA-O-BENZYL-3-DEOXY-D-GLYCERO-D-GALACTO-HEPTITOL
2,3,4,6-TETRA-O-BENZYL-D-GLUCONHYDROXIMO-1,5-LACTAM
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and biological evaluation of nojirimycin- and pyrrolidine-based trehalase inhibitors | Beilstein Journal of Organic Chemistry | 2012 |